Transcription of eukaryotic protein-coding genes

Annual Review of Genetics

Volumn 34, Issue , 2000, Pages 77-137

  Tong Ihn Lee, ^a   Young, R A ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Activation and repression; Chromatin modification; Gene expression; RNA polymerase II holoenzyme; Srb Mediator complex

Indexed keywords

HOLOENZYME; MESSENGER RNA; PROTEIN; PROTEIN MED; PROTEIN SRB; RNA POLYMERASE II; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

CHROMATIN STRUCTURE; EUKARYOTE; GENE ACTIVATION; GENE EXPRESSION; GENE REPRESSION; GENETIC CODE; GENETIC TRANSCRIPTION; MESSENGER RNA SYNTHESIS; PRIORITY JOURNAL; REVIEW; RNA PROCESSING; RNA TRANSLATION; TRANSCRIPTION REGULATION;

CHROMATIN; EUKARYOTIC CELLS; GENE EXPRESSION REGULATION; PEPTIDE ELONGATION FACTORS; RNA POLYMERASE II; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EUKARYOTA;

EID: 0034507632     PISSN: 00664197     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.genet.34.1.77     Document Type: Review

References (251)

1. The SANT domain: A putative DNA-binding domain in the SWI-SNF and ADA complexes, the transcriptional co-repressor N-CoR and TFIIIB
2. The HIV-1 Vpr co-activator induces a conformational change in TFIIB
3. Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression
4. Mutations in RNA polymerase II enhance or suppress mutations in GAL4
5. The C-terminal domain of the largest subunit of RNA polymerase II of Saccharomyces cerevisiae, Drosophila melanogaster, and mammals: A conserved structure with an essential function
6. BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A
7. Relationship between methylation and acetylation of arginine-rich histones in cycling and arrested HeLa cells
8. CpG islands as genomic footprints of promoters that are associated with replication origins
9. Broad, but not universal, transcriptional requirement for yTAFII17, a histone H3-like TAFII present in TFIID and SAGA
10. Yeast TAF(II)90 is required for cell-cycle progression through G2/M but not for general transcription activation
11. An essential component of a C-terminal domain phosphatase that interacts with transcription factor IIF in Saccharomyces cerevisiae
12. Genetics of eukaryotic RNA polymerases I, II, and III
13. FCP1, the RAP74-interacting subunit of a human protein phosphatase that dephosphorylates the carboxyl-terminal domain of RNA polymerase IIO
14. Role of core promoter structure in assembly of the RNA polymerase II preinitiation complex. A common pathway for formation of preinitiation intermediates at many TATA and TATA-less promoters
15. Elongin (SIII): A multisubunit regulator of elongation by RNA polymerase II
16. Two conformations of RNA polymerase II revealed by electron crystallography
17. Mot1, a global repressor of RNA polymerase II transcription, inhibits TBP binding to DNA by an ATP-dependent mechanism
18. Molecular analysis of the SNF2/SWI2 protein family member MOT1, an ATP-driven enzyme that dissociates TATA-binding protein from DNA
19. Histone deacetylases: Transcriptional repression with SINers and NuRDs
20. Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3
21. The CCR4 and CAF1 proteins of the CCR4-NOT complex are physically and functionally separated from NOT2, NOT4, and NOT5
22. The Med1 subunit of the yeast mediator complex is involved in both transcriptional activation and repression
23. Three sub-units of the RNA polymerase II mediator complex are involved in glucose repression
24. The CBP co-activator is a histone acetyltransferase
25. Recruitment of the RNA polymerase II holoenzyme and its implications in gene regulation
26. Delineation of two functional regions of transcription factor TFIIB
27. Contact with a component of the polymerase II holoenzyme suffices for gene activation
28. RNA contacts subunits IIo and IIc in HeLa RNA polymerase II transcription complexes
29. Identification of mouse histone deacetylase 1 as a growth factor-inducible gene
30. Genetic analysis of the repetitive carboxyl-terminal domain of the largest subunit of mouse RNA polymerase II
31. Linker histones: Paradigm lost but questions remain
32. The establishment of active chromatin domains
33. Stopped at the border: Boundaries and insulators
34. Interplay between chromatin modifying and remodeling complexes in transcriptional regulation
35. Role of the mammalian transcription factors IIF, IIS, and IIX during elongation by RNA polymerase II
36. Association of distinct yeast Not2 functional domains with components of Gcn5 histone acetylase and Ccr4 transcriptional regulatory complexes
37. Coupling RNA polymerase II transcription with pre-mRNA processing
38. Gene activation by histone and factor acetyltransferases
39. Activation of RNA polymerase II transcription
40. The sua8 suppressors of Saccharomyces cerevisiae encode replacements of conserved residues within the largest subunit of RNA polymerase II and affect transcription start site selection similarly to sua7 (TFIIB) mutations
41. Methylation-induced repression - Belts, braces, and chromatin
42. Mediator of transcriptional regulation
43. Going the distance: A current view of enhancer action
44. The histone acetylase PCAF is a nuclear receptor coactivator
45. Three functional classes of transcriptional activation domain
46. Preferential DNA repair in active genes
47. A serine/arginine-rich nuclear matrix cyclophilin interacts with the C-terminal domain of RNA polymerase II
48. Mammalian Srb/Mediator complex is targeted by adenovirus E1A protein
49. Regulation of activity of the transcription factor GATA-1 by acetylation
50. Reversible histone modifications and the chromosome cell cycle
51. Distinct roles for the helicases of TFIIH in transcript initiation and promoter escape
52. RNA polymerase II transcription factor SIII. I. Identification, purification, and properties
53. RNA polymerase II transcription factor SIII. II. Functional properties and role in RNA chain elongation
54. Identification of TATA-binding protein-free TAFII-containing complex subunits suggests a role in nucleosome acetylation and signal transduction
55. RNA editing
56. The many HATs of transcription coactivators
57. Transcriptional activation domains stimulate initiation and elongation at different times and via different residues
58. Special HATs for special occasions: Linking histone acetylation to chromatin assembly and gene activation
59. Tetrahymena histone acetyltransferase A: A homolog to yeast Gcn5p linking histone acetylation to gene activation
60. ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCRalpha enhancer function
61. Looping versus linking: Toward a model for long-distance gene activation
62. The basics of basal transcription by RNA polymerase II
63. Five intermediate complexes in transcription initiation by RNA polymerase II
64. Functional domains of transcription factor TFIIB
65. Drosophila TFIID binds to a conserved downstream basal promoter element that is present in many TATA-box-deficient promoters
66. The downstream core promoter element, DPE, is conserved from Drosophila to humans and is recognized by TAFII60 of Drosophila
67. X-ray crystallographic studies of eukaryotic transcription initiation factors
68. Biochemistry and structural biology of transcription factor IID (TFIID)
69. Chromatin structure is required to block transcription of the methylated herpes simplex virus thymidine kinase gene
70. A minimal set of RNA polymerase II transcription protein interactions
71. MOT2 encodes a negative regulator of gene expression that affects basal expression of pheromone-responsive genes in Saccharomyces cerevisiae
72. Messenger RNA synthesis in mammalian cells is catalyzed by the phosphorylated form of RNA polymerase II
73. Chromatin remodeling machines: Similar motors, ulterior motives
74. A multisubunit complex containing the SWI1/ADR6, SWI2/SNF2, SWI3, SNF5, and SNF6 gene products isolated from yeast
75. RSC, an essential, abundant chromatin-remodeling complex
76. Identification of proliferation-induced genes in Arabidopsis thaliana. Characterization of a new member of the highly evolutionarily conserved histone H2A.F/Z variant sub-family
77. The initiator directs the assembly of a transcription factor IID-dependent transcription complex
78. The enhanceosome and transcriptional synergy
79. Genetics of transcriptional regulation in yeast: Connections to the RNA polymerase II CTD
80. Increased Ser-10 phosphorylation of histone H3 in mitogen-stimulated and oncogene-transformed mouse fibroblasts
81. Identification and purification of a yeast protein that affects elongation by RNA polymerase II
82. Purification and characterization of a phosphatase from HeLa cells which dephosphorylates the C-terminal domain of RNA polymerase II
83. Purification and characterization of an RNA polymerase II phosphatase from yeast
84. The activity of COOH-terminal domain phosphatase is regulated by a docking site on RNA polymerase II and by the general transcription factors IIF and IIB
85. Eukaryotic nuclear RNA polymerases
86. A complex containing RNA polymerase II, Paf1p, Cdc73p, Hpr1p, and Ccr4p plays a role in protein kinase C signaling
87. A multiplicity of mediators: Alternative forms of transcription complexes communicate with transcriptional regulators
88. A mammalian SRB protein associated with an RNA polymerase II holoenzyme
89. Crystal structure of yeast TATA-binding protein and model for interaction with DNA
90. Connecting a promoter-bound protein to TBP bypasses the need for a transcriptional activation domain
91. Med8, a subunit of the mediator CTD complex of RNA polymerase II, directly binds to regulatory elements of SUC2 and HXK2 genes
92. Nucleosome-mediated synergism between transcription factors on the mouse mammary tumor virus promoter
93. Regulation of transcription by a protein methyltransferase
94. Nuclear receptor coactivator ACTR is a novel histone acetyl-transferase and forms a multimeric activation complex with P/CAF and CBP/p300
95. Coactivation and corepression in transcriptional regulation by steroid/nuclear hormone receptors
96. The interaction of RNA polymerase II with the adenovirus-2 major late promoter is precluded by phosphorylation of the C-terminal domain of subunit IIa
97. Allosteric interactions between capping enzyme subunits and the RNA polymerase II carboxy-terminal domain
98. mRNA capping enzyme is recruited to the transcription complex by phosphorylation of the RNA polymerase II carboxy-terminal domain
99. A protein phosphatase functions to recycle RNA polymerase II
100. Affinity purification of a human RNA polymerase II complex using monoclonal antibodies against transcription factor IIF
101. Affinity purification of a human RNA polymerase II complex using monoclonal antibodies against transcription factor IIF
102. A human RNA polymerase II complex containing factors that modify chromatin structure
103. A portion of RNA polymerase II molecules has a component essential for stress responses and stress survival
104. Transcriptional activation by TFIIB mutants that are severely impaired in interaction with promoter DNA and acidic activation domains
105. An early developmental transcription factor complex that is more stable on nucleosome core particles than on free DNA
106. Regions of variant histone His2AvD required for Drosophila development
107. Ten years of TFIIH
108. The NOT, SPT3, and MOT1 genes functionally interact to regulate transcription at core promoters
109. CDC39, an essential nuclear protein that negatively regulates transcription and differentially affects the constitutive and inducible HIS3 promoters
110. NOT1 (CDC39), NOT2(CDC36), NOT3, and NOT4 encode a global-negative regulator of transcription that differentially affects TATA-element utilization
111. Mechanism of promoter escape by RNA polymerase II
112. General initiation factors for RNA polymerase II
113. General transcription factors for RNA polymerase II
114. Stress and developmental regulation of the yeast C-type cyclin Ume3p (Srb11p/Ssn8p)
115. Tails of RNA polymerase II
116. A CTD function linking transcription to splicing
117. The TATA-binding protein is required for transcription by all three nuclear RNA polymerases in yeast cells
118. ISWI is an ATP-dependent nucleosome remodeling factor
119. Factors involved in specific transcription by mammalian RNA polymerase II: Purification and analysis of transcription factor IIA and identification of transcription factor IIJ
120. Ordered recruitment of transcription and chromatin remodeling factors to a cell cycle- and developmentally-regulated promoter
121. Stimulation of GAL4 derivative binding to nucleosomal DNA by the yeast SWI/SNF complex
122. DNA bending and wrapping around RNA polymerase: A "revolutionary" model describing transcriptional mechanisms
123. Architecture of RNA polymerase II and implications for the transcription mechanism
124. Coupling of transcription with alternative splicing: RNA pol II promoters modulate SF2/ASF and 9G8 effects on an exonic splicing enhancer
125. Functional association between promoter structure and transcript alternative splicing
126. The human immunodeficiency virus transactivator Tat interacts with the RNA polymerase II holoenzyme
127. RNA surveillance. Unforeseen consequences for gene expression, inherited genetic disorders and cancer
128. Reversible phosphorylation of the C-terminal domain of RNA polymerase II
129. Inhibition of transcription selectively reduces the level of ubiquitinated histone H2B in chromatin
130. Control of histone modifications
131. Rsk-2 activity is necessary for epidermal growth factor-induced phosphorylation of CREB protein and transcription of c-fos gene
132. Human general transcription factor TFIIA: Characterization of a cDNA encoding the small subunit and requirement for basal and activated transcription
133. Purification of ribosomal proteins from Escherichia coli under nondenaturing conditions
134. A role for transcriptional repressors in targeting the yeast Swi/Snf complex
135. Dual role of TFIIH in DNA excision repair and in transcription by RNA polymerase II
136. A functional interaction between the carboxy-terminal domain of RNA polymerase II and pre-mRNA splicing
137. Inhibition of transcription elongation by the VHL tumor suppressor protein
138. Inhibitors of transcription such as 5, 6-dichloro-1-beta-D-ribofuranosylbenzimidazole and isoquinoline sulfonamide derivatives (H-8 and H-7) promote dephosphorylation of the carboxyl-terminal domain of RNA polymerase II largest subunit
139. Nucleosome loss activates CUP1 and HIS3 promoters to fully induced levels in the yeast Saccharomyces cerevisiae
140. Yeast histone H4 N-terminal sequence is required for promoter activation in vivo
141. A role for TFIIH in controlling the activity of early RNA polymerase II elongation complexes
142. Ku autoantigen is the regulatory component of a template-associated protein kinase that phosphorylates RNA polymerase II
143. The ADA complex is a distinct histone acetyl-transferase complex in Saccharomyces cerevisiae
144. p300 and CBP as transcriptional regulators and targets of oncogenic events
145. Two dissociable subunits of yeast RNA polymerase II stimulate the initiation of transcription at a promoter in vitro
146. Restriction of interferon gamma responsiveness and basal expression of the myeloid human Fc gamma R1b gene is mediated by a functional PU.1 site and a transcription initiator consensus
147. Mechanism of synergy between TATA and initiator: Synergistic binding of TFIID following a putative TFIIA-induced isomerization
148. A novel yeast protein influencing the response of RNA polymerase II to transcriptional activators
149. Characterization of a human RPD3 ortholog, HDAC3
150. Looping, linking, and chromatin activity: New insights into beta-globin locus regulation
151. A cyclin-dependent kinase-activating kinase (CAK) in budding yeast unrelated to vertebrate CAK
152. Mutations in the RNA polymerase II transcription machinery suppress the hyperrecombination mutant hpr1 delta of Saccharomyces cerevisiae
153. Gene activation by recruitment of the RNA polymerase II holoenzyme
154. CTD kinase associated with yeast RNA polymerase II initiation factor b
155. Genes for Tfb2, Tfb3, and Tfb4 subunits of yeast transcription/repair factor IIH. Homology to human cyclin-dependent kinase activating kinase and IIH subunits
156. The MO15 gene encodes the catalytic subunit of a protein kinase that activates cdc2 and other cyclin-dependent kinases (CDKs) through phosphorylation of Thr161 and its homologues
157. A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase
158. A mediator required for activation of RNA polymerase II transcription in vitro
159. Core histone tail domains mediate oligonucleosome folding and nucleosomal DNA organization through distinct molecular mechanisms
160. The nucleosomal array: Structure/function relationships
161. Factors involved in specific transcription by mammalian RNA polymerase II. Identification and characterization of factor IIH
162. Factors involved in specific transcription by mammalian RNA polymerase II. RNA polymerase II-associating protein 30 is an essential component of transcription factor IIF
163. Factors involved in specific transcription by mammalian RNA polymerase II. Factors IIE and IIF independently interact with RNA polymerase II
164. Thyroid hormone receptor-associated proteins and general positive cofactors mediate thyroid hormone receptor function in the absence of the TATA box-binding protein-associated factors of TFIID
165. Lig- and induction of a transcriptionally active thyroid hormone receptor coactivator complex
166. Locus control regions, chromatin activation and transcription
167. Regena (Rga), a Drosophila homolog of the global negative transcriptional regulator CDC36 (NOT2) from yeast, modifies gene expression and suppresses position effect variegation
168. Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex
169. Cyclin K functions as a CDK9 regulatory subunit and participates in RNA polymerase II transcription
170. The ability of positive transcription elongation factor B to transactivate human immunodeficiency virus transcription depends on a functional kinase domain, cyclin T1, and Tat
171. Functional antagonism between RNA polymerase II holoenzyme and global negative regulator NC2 in vivo
172. HIV-1 Tat: Coping with negative elongation factors
173. Purification of a Tat-associated kinase reveals a TFIIH complex that modulates HIV-1 transcription
174. Modulation of chromatin folding by histone acetylation
175. Transcription of the lymphocyte-specific terminal deoxynucleotidyltransferase gene requires a specific core promoter structure
176. Activation of transcription in vitro by recruitment of the yeast RNA polymerase II holoenzyme
177. RNA polymerase II holoenzyme recruitment is sufficient to remodel chromatin at the yeast PHO5 promoter
178. The high mobility group protein HMG1 can reversibly inhibit class II gene transcription by interaction with the TATA-binding protein
179. Isolation of cDNAs encoding novel transcription coactivators p52 and p75 reveals an alternate regulatory mechanism of transcriptional activation
180. A novel transcriptional coactivator, p52, functionally interacts with the essential splicing factor ASF/SF2
181. Lack of an initiator element is responsible for multiple transcriptional initiation sites of the TATA-less mouse thymidylate synthase promoter
182. Role of histone tails in nucleosome remodeling by Drosophila NURF
183. RNA polymerase II C-terminal domain required for enhancer-driven transcription
184. Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions
185. p300 and CBP: Partners for life and death
186. Viral transactivators E1A and VP16 interact with a large complex that is associated with CTD kinase activity and contains CDK8
187. PITALRE, the catalytic subunit of TAK, is required for human immunodeficiency virus Tat transactivation in vivo
188. Synergistic and promoter-selective activation of transcription by recruitment of transcription factors TFIID and TFIIB
189. TBP-TAF complexes: Selectivity factors for eukaryotic transcription
190. Characterization of the basal inhibitor of class II transcription NC2 from Saccharomyces cerevisiae
191. A mechanism for repression of class II gene transcription through specific binding of NC2 to TBP-promoter complexes via heterodimeric histone fold domains
192. Global steps during initiation by RNA polymerase II
193. A subset of TAF(II)s are integral components of the SAGA complex required for nucleosome acetylation and transcriptional stimulation
194. Yeast Gcn5 functions in two multisubunit complexes to acetylate nucleosomal histones: Characterization of an Ada complex and the SAGA (Spt/Ada) complex
195. Expanded lysine acetylation specificity of Gcn5 in native complexes
196. TBP-associated factors (TAFIIs): Multiple, selective transcriptional mediators in common complexes
197. RNA polymerase-associated transcription factors
198. RNA polymerase II holoenzyme and transcriptional regulation
199. Higher-order nucleoprotein complexes in transcription: Analogies with site-specific recombination
200. Activation by locus control regions?
201. Three proteins define a class of human histone deacetylases related to yeast Hda1p
202. Histone acetylation in chromatin structure and transcription
203. A novel human SRB/MED-containing cofactor complex, SMCC, involved in transcription regulation
204. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain
205. Diverse and dynamic functions of the Sir silencing complex
206. Involvement of TFIID and USA components in transcriptional activation of the human immunodeficiency vires promoter by NF-kappaB and Sp1
207. Identification of new mediator subunits in the RNA polymerase II holoenzyme from Saccharomyces cerevisiae
208. Stable remodeling of tailless nucleosomes by the human SWI-SNF complex
209. Transcription factor TFIIH is required for promoter melting in vivo
210. Activation and the role of reinitiation in the control of transcription by RNA polymerase II
211. Yeast TATA-binding protein TFIID binds to TATA elements with both consensus and nonconsensus DNA sequences
212. Molecular genetics of the RNA polymerase II general transcriptional machinery
213. RNA polymerase II as a control panel for multiple coactivator complexes
214. Nucleosome loss activates yeast downstream promoters in vivo
215. Depletion of histone H4 and nucleosomes activates the PHO5 gene in Saccharomyces cerevisiae
216. Active repression mechanisms of eukaryotic transcription repressors
217. TAFs and TFIIA mediate differential utilization of the tandem Adh promoters
218. Evidence that Spt4, Spt5, and Spt6 control transcription elongation by RNA polymerase II in Saccharomyces cerevisiae
219. Histone deacetylase activity is required for full transcriptional repression by mSin3A
220. Core histone hyperacetylation co-maps with generalized DNase I sensitivity in the chicken beta-globin chromosomal domain
221. A direct link between core histone acetylation and transcriptionally active chromatin
222. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression
223. Mutations in a conserved region of RNA polymerase II influence the accuracy of mRNA start site selection
224. Distribution of methylated histones and histone methyltransferases in chicken erythrocyte chromatin
225. Dynamically acetylated histones of chicken erythrocytes are selectively methylated
226. Temporal regulation of RNA polymerase II by Srb10 and Kin 28 cyclin-dependent kinases
227. Association of an activator with an RNA polymerase II holoenzyme
228. A perfect message: RNA surveillance and nonsense-mediated decay
229. Specific acetylation of chromosomal protein HMG-17 by PCAF alters its interaction with nucleosomes
230. Mechanisms of mRNA surveillance in eukaryotes
231. RNA polymerase II is an essential mRNA polyadenylation factor
232. Phosphorylated RNA polymerase II stimulates pre-mRNA splicing
233. GAL4 is regulated by the RNA polymerase II holoenzyme-associated cyclin-dependent protein kinase SRB10/CDK8
234. Distinct roles for CTD Ser-2 and Ser-5 phosphorylation in the recruitment and allosteric activation of mammalian mRNA capping enzyme
235. The guanylyltransferase domain of mammalian mRNA capping enzyme binds to the phosphorylated carboxyl-terminal domain of RNA polymerase II
236. Three transitions in the RNA polymerase II transcription complex during initiation
237. Dissecting the regulatory circuitry of a eukaryotic genome
238. The requirement for the basal transcription factor lIE is determined by the helical stability of promoter DNA
239. Opening of an RNA polymerase II promoter occurs in two distinct steps and requires the basal transcription factors IIE and IIH
240. Cloning and characterization of a novel human class I histone deacetylase that functions as a transcription repressor
241. RNA polymerase II subunit RPB9 is required for accurate start site selection
242. p44 and p34 subunits of the BTF2/TFIIH transcription factor have homologies with SSL1, a yeast protein involved in DNA repair
243. CREB-binding protein acetylates hematopoietic transcription factor GATA-1 at functionally important sites
244. Activation domain-specific and general transcription stimulation by native histone acetyltransferase complexes
245. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
246. Energy-dependent chromatin remodelers: Complex complexes and their components
247. Facilitated binding of TATA-binding protein to nucleosomal DNA
248. Transcription factor (TF) IIB and TFIIA can independently increase the affinity of the TATA-binding protein for DNA
249. Transcription: Gene control by targeted histone acetylation
250. Purification and properties of the Xenopus Hat1 acetyltransferase: Association with the 14-3-3 proteins in the oocyte nucleus
251. Acetylation of general transcription factors by histone acetyltransferases